Carcinogenesis and Dietary Fat - Prostaglandins, Leukotrienes, and Cancer 6 (Paperback)
  • Carcinogenesis and Dietary Fat - Prostaglandins, Leukotrienes, and Cancer 6 (Paperback)
zoom

Carcinogenesis and Dietary Fat - Prostaglandins, Leukotrienes, and Cancer 6 (Paperback)

(editor)
£279.99
Paperback 492 Pages / Published: 27/09/2011
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket
Prostaglandins, Leukotrienes, and Cancer is a multi-volume series which focuses on an emerging area of cancer research. In 1968, R. H. Williams first reported that elevated prostaglandin levels are present in human medullary carcinoma. Since that time, the concept that arachidonic acid metabolites may be involved in cancer has expanded to include every aspect of the disease from cell transformation through metastasis. Prostaglandins and leukotrienes are generic terms used to describe a family ofbioactive lipids produced from unsaturated fatty acids (principally from arachidonic acid) via the cyclooxygenase and lipoxygenase pathways, respectively. Cyclooxygenase products consist of diverse products such as prostaglandin E2 (PGE2), prostacyclin (PGI2) and thromboxane A2 (TXA2), whereas lipoxygenase products consist ofhydroperoxy fatty acids and mono-, di-and tri-hydroxy acids including leukotrienes, lipoxins, and epoxides. The precursor fatty acids for the cyclooxygenase and lipoxygenase pathways are present in cellular phospholipids. This finding established an important control point in their biosynthesis --the release of substrate. This occurs in response to numerous stimuli that act at the cell surface. Dr. Bengt Samuelsson's extensive study ofthe metabolism of prostaglandins indicate that they are rapidly inactivated on a single pass through pulmonary circulation. Thus, they cannot act as circulating hormones and appear to be made on demand in the vicinity oftarget tissues leading to the concept that prostaglandins are local rrormones or autocoids. Altered production, qualitative and/or quantitative, of prostaglandins and leukotrienes has been implicated in the development of a number of disease states (e. g.

Publisher: Springer-Verlag New York Inc.
ISBN: 9781461288787
Number of pages: 492
Weight: 783 g
Dimensions: 235 x 155 x 26 mm
Edition: Softcover reprint of the original 1st ed. 198

You may also be interested in...

Cancer Care
Added to basket
£7.99
Paperback
Laws of Medicine
Added to basket
Oxford Handbook of Clinical Haematology
Added to basket
£34.99
Part-work (fascículo)
B is for Breast Cancer
Added to basket
The Cancer Survivor's Companion
Added to basket
Cancer: A Very Short Introduction
Added to basket
The Emperor of All Maladies
Added to basket
Cancer
Added to basket
£12.50
Paperback
The Biology of Cancer
Added to basket
When I Die
Added to basket
£8.99
Paperback
Beating Cancer with Nutrition
Added to basket
Oxford Handbook of Oncology
Added to basket
£34.99
Part-work (fascículo)
Coping with Chemotherapy
Added to basket
The End of Your Life Book Club
Added to basket

Reviews

Please sign in to write a review

Your review has been submitted successfully.